Descrição

Body weight monitoring data across the study period show no significant differences between valerian-treated and control groups, suggesting the extract is well-tolerated at the tested doses.

Figure 321

Chart

Source Paper

Impact of a Novel Valerian Extract on Sleep Quality, Relaxation, and GABA/Serotonin Receptor Activity in a Murine Model.

Antioxidants (Basel, Switzerland) (2024)

PMID: 38929096

DOI: 10.3390/antiox13060657

Cite This Figure

![Figure 321: Body weight monitoring data across the study period show no significant differences between valerian-treated and control groups, suggesting the extract is well-tolerated at the tested doses.]()

> Source: Kazim Sahin et al. "Impact of a Novel Valerian Extract on Sleep Quality, Relaxation, and GABA/Seroto." *Antioxidants (Basel, Switzerland)*, 2024. PMID: [38929096](https://pubmed.ncbi.nlm.nih.gov/38929096/)

<figure>
  <img src="" alt="Body weight monitoring data across the study period show no significant differences between valerian-treated and control groups, suggesting the extract is well-tolerated at the tested doses." />
  <figcaption>Figure 321. Body weight monitoring data across the study period show no significant differences between valerian-treated and control groups, suggesting the extract is well-tolerated at the tested doses.<br>  Source: Kazim Sahin et al. "Impact of a Novel Valerian Extract on Sleep Quality, Relaxation, and GABA/Seroto." <em>Antioxidants (Basel, Switzerland)</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38929096/">38929096</a></figcaption>
</figure>

Evidências Relacionadas

Melatonin para Sleep-Related Cognitive Impairment

Nota C · 15 estudos